Network Pharmacology of Thalictrum simplex var. brevipes: Linking Chemical Constituents to Hepatitis Treatment Targets
Article Sidebar
Main Article Content
Abstract
Thalictrum simplex var. brevipes has been used for the treatment of hepatitis. However, its chemical constituents and their corresponding bioactivities remain uncertain. This study aims to identify chemical constituents of T. simplex var. brevipes and to develop a network pharmacology model to enhance the understanding of T. simplex var. brevipes in the treatment of hepatitis. SwissTargetPrediction was employed to identify potential therapeutic targets of the identified compounds. Hepatitis-associated genes were sourced from the GeneCards database, and Venn analysis was conducted to reveal overlaps between these hepatitis genes and the predicted targets. Common targets were then subjected to protein-protein interaction (PPI) analysis using STRING. Key genes were further validated through KEGG pathway analysis. Finally, a compound-target-pathway network was constructed using Cytoscape (version 3.7.2), integrating hepatitis-linked genes with the common targets. The 13 identified compounds shared 423 unique common targets with hepatitis, with each compound having over 70 associated targets. The protein-protein interaction (PPI) network highlighted key hepatitis-related targets, specifically HSP90AA1, SRC, and EGFR. KEGG analysis revealed that 213 pathways were linked to these common targets, including significant pathways related to hepatitis B and C. This study indicated that the potential therapeutic effects of T. simplex var. brevipes may derive from its diverse compounds, which can influence targets and pathways related to hepatitis treatment.
Downloads
Article Details
Section
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
How to Cite
References
. Soriano V, Moreno-Torres V, Treviño A, Jesús F de, Corral O, Mendoza C de. Prospects for controlling hepatitis B globally. Pathogens. 2024; 13(4):291–202.
2. Singh H, Singh D, Lekhak MM. Ethnobotany, botany, phytochemistry and ethnopharmacology of the genus Thalictrum L. (Ranunculaceae): A review. J Ethnopharmacol. 2023; 305:115950.
3. Marslin G, Prakash J. Hepatoprotective Activity of Thalictrum Foliolosum (Ranunculaceae) Root Ethanolic Extract. Int J Life Sci Pharma Res. 2020; 10(3):8–11.
4. Arba M, Ihsan S, Mazida M, Jamili J, Wahyuni T. Network Pharmacology-Based Prediction of the Mechanism of Anti-Hepatitis C Virus of Kleinhovia Hospita L. Trop J Nat Prod Res. 2025; 9(9):4460–4467.
5. Zubair MS, Yuyun Y, Musnina WS, Najib A, Nainu F, Arba M, Paneo DR, Praditapuspa EN, Maulana S. Network Pharmacology and Molecular Docking Studies of Ethnopharmacological Plants from Sulawesi as Antidiabetics. Trop J Nat Prod Res. 2025; 9(3):1123–1135.
6. Wang S, Lee HC, Lee S. Predicting herb-disease associations using network-based measures in human protein interactome. BMC Complement Med Ther. 2024; 24(S2):218–229.
7. Kuok C-F, Song M, Hou-Tong U, Chong C-L, Zeng Q-Q, Zhang Q-W. Two new cycloartane glycosides from the aerial parts of Thalictrum simplex subsp. amurense. Biochem Syst Ecol. 2025; 123:105074.
8. Daina A, Zoete V. Testing the predictive power of reverse screening to infer drug targets, with the help of machine learning. Commun Chem. 2024; 7(1):105–113.
9. Szklarczyk D, Nastou K, Koutrouli M, Kirsch R, Mehryary F, Hachilif R, Hu D, Peluso ME, Huang Q, Fang T. The STRING database in 2025: protein networks with directionality of regulation. Nucl Acids Res. 2025; 53(D1):D730–D737.
10. Safran M, Rosen N, Twik M, BarShir R, Stein TI, Dahary D, Fishilevich S, Lancet D. The GeneCards Suite. In: Abugessaisa I, Kasukawa T, editors. Practical Guide to Life Science Databases. Singapore: Springer Nature, 2021; 27–56.
11. Kanehisa M, Furumichi M, Sato Y, Matsuura Y, Ishiguro-Watanabe M. KEGG: biological systems database as a model of the real world. Nucl Acids Res. 2025; 53(D1):D672–D677.
12. Ono K, Fong D, Gao C, Churas C, Pillich R, Lenkiewicz J, Pratt D, Pico AR, Hanspers K, Xin Y. Cytoscape Web: bringing network biology to the browser. Nucleic Acids Res. 2025; 53(W1):W203–212.
13. Roy A, Roy M, Gacem A, Datta S, Zeyaullah M, Muzammil K, Farghaly TA, Abdellattif MH, Yadav KK, Simal-Gandara J. Role of bioactive compounds in the treatment of hepatitis: A review. Front Pharmacol. 2022; 13:1051751.
14. Shaukat Z, Aiman S, Li C-H. Protein-protein interactions: Methods, databases, and applications in virus-host study. World J Virol. 2021; 10(6):288–300.
15. Wang S, Wu R, Lu J, Jiang Y, Huang T, Cai Y. Protein‐protein interaction networks as miners of biological discovery. Proteomics. 2022; 22(15–16):2100190.
16. Kim S-H, Hwang S, Song G-W, Jung D-H, Moon D-B, Yang JD, Yu HC. Identification of key genes and carcinogenic pathways in hepatitis B virus-associated hepatocellular carcinoma through bioinformatics analysis. Ann Hepatobiliary Pancreat Surg. 2022; 26(1):58–68.
17. Yang L, Zhang Y-H, Huang F, Li Z, Huang T, Cai Y-D. Identification of protein–protein interaction associated functions based on gene ontology and KEGG pathway. Front Genet. 2022; 13:1011659.
18. Chen K, Gao Z. Acacetin, a Natural Flavone with Potential in Improving Liver Disease Based on Its Anti-Inflammation, Anti-Cancer, Anti-Infection and Other Effects. Molecules. 2024; 29(20):4872–4891.
19. Takizawa R, Minamizono T, Tsuji D, Yan X-J, Lu F-L, Yang X-R, Li D-P, Akagi R, Kashiwada Y, Tanaka N. Methoxyflavone glucosides and caffeoyl phenylethanoid glycoside from Lysionotus pauciflorus: their structures and anti-ferroptosis activity. J Nat Med. 2025; 79(1):196–203.
20. Zhang Y, Fu Q, Wu T, Liu K, Xiao Y, Liao Q, Qi X, Li Y, Zhou L. 5-Methoxyflavone ameliorates non-alcoholic fatty liver disease through targeting the cytochrome P450 1A1. Free Radic Biol Med. 2023; 195:178–191.
21. Peng X, Shi Y, Zhang B, Xu C, Lang J. Establishment of nucleic acid sensing pathways-based model in predicting response to immunotherapy and targeted drug in hepatitis virus-related hepatocellular carcinoma. J Med Virol. 2023; 95(9):e29084. 22. Kurniawan DW, Storm G, Prakash J, Bansal R. Role of spleen tyrosine kinase in liver diseases. World J Gastroenterol. 2020; 26(10):1005–1019.
23. Kurniawan DW, Booijink R, Jajoriya AK, Dhawan G, Mishra D, Oosterhuis D, Argemi J, Storm G, Olinga P, Bataller R, Mohanty SK, Mishra DP, Prakash J, Bansal R. Src kinase as a potential therapeutic target in non‐alcoholic and alcoholic steatohepatitis. Clinical and Translational Dis. 2022; 2(1):e18.
24. Chuang Y-C, Tsai K-N, Ou J-HJ. Pathogenicity and virulence of Hepatitis B virus. Virulence. 2022; 13(1):258–296.
25. Chaudhari R, Fouda S, Sainu A, Pappachan JM. Metabolic complications of hepatitis C virus infection. World J Gastroenterol. 2021; 27(13):1267–1282.
26. Stuart JD, Salinas E, Grakoui A. Immune system control of hepatitis C virus infection. Curr Opin Virol. 2021; 46:36–44.
27. Wang Z, Jin Z, Xiong Z. Research progress of epidermal growth factor receptor in metabolic dysfunction‐associated steatotic liver disease and related diseases. Diabetes Obes Metab. 2025; 27(10):5418–5431.
28. Nishitsuji H, Naito Y, Murakami Y, Sugiyama M, Mizokami M, Shoji I, Murata T, Shimotohno K. Identification of glycogen synthase kinase 3alpha/beta as a host factor required for hepatitis B virus transcription using high-throughput screening. Hepatology. 2025; 1:1–14.
29. Sehgal R, Perfilyev A, Männistö V, Ågren J, Nilsson E, Käkelä P, Ling C, Mello VD de, Pihlajamäki J. Liver saturated fat content associates with hepatic DNA methylation in obese individuals. Clin Epigenet. 2023; 15(1):21–33.
30. Liu D, Zhu K, Guo T, Xiao Y, Wang M, Guan Y, Li J, Chang D, Yu X. Chrysophanol: A promising natural compound in cancer therapy – Mechanistic insights and future perspectives. Pharmacol Res. 2024; 210:107502.
31. Wang T, Lu Z, Qu X-H, Xiong Z-Y, Wu Y-T, Luo Y, Zhang Z-Y, Han X-J, Xie C-F. Chrysophanol-8-O-glucoside protects mice against acute liver injury by inhibiting autophagy in hepatic stellate cells and inflammatory response in liver-resident macrophages. Front Pharmacol. 2022; 13:951521.